Nuveen’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Nuveen’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,500	Closed	-$100K	–	3219
2023 Q2	$100K	Hold	33,500	–	–	﹤0.01%	3166
2023 Q1	$116K	Hold	33,500	–	–	﹤0.01%	3047
2022 Q4	$140K	Sell	33,500 -38,700	-54%	-$147K	﹤0.01%	3080
2022 Q3	$290K	Buy	72,200 +19,900	+38%	+$151K	﹤0.01%	3051
2022 Q2	$591K	Sell	52,300 -5,700	-10%	-$68.3K	﹤0.01%	2974
2022 Q1	$942K	Sell	58,000 -14,600	-20%	-$374K	﹤0.01%	2834
2021 Q4	$3.44M	Sell	72,600 -22,000	-23%	-$1.32M	﹤0.01%	2305
2021 Q3	$6.86M	Buy	94,600 +42,700	+82%	+$3.09M	﹤0.01%	2042
2021 Q2	$4.36M	Buy	+51,900	New	+$3.42M	﹤0.01%	2319

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nuveen's NBP Position: Q3 2023 in Review

Nuveen sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 33,500 shares — an estimated $100K sold.

Nuveen first reported a position in NBP in Q2 2021 and held it in 9 quarters. The position peaked at $6.86M in Q3 2021. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

Nuveen reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Nuveen sold 33,500 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $100K.
Nuveen first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 9 quarters.
Nuveen's NovaBridge Biosciences American Depositary Shares position peaked at $6.86M in Q3 2021.
47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.